Cover Image

Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act

Show other versions (1)

Background - Rare rheumatologic diseases are a heterogeneous group of conditions associated with high morbidity. As a whole group, rare rheumatologic diseases afflict millions of people demanding for effective therapies. Therefore, we analyzed the impact of the US Orphan Drug Act on the development...

Full description

Saved in:
Bibliographic Details
Main Authors: Lutz, Thomas (Author) , Lampert, Anette (Author) , Hoffmann, Georg F. (Author) , Ries, Markus (Author)
Format: Article (Journal)
Language:English
Published: 2016 May 12
In: Orphanet journal of rare diseases
Year: 2016, Volume: 11, Pages: 1-8
ISSN:1750-1172
DOI:10.1186/s13023-016-0443-x
Online Access:Verlag, Volltext: https://doi.org/10.1186/s13023-016-0443-x
Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866287/
Get full text
Author Notes:Thomas Lutz, Anette Lampert, Georg F. Hoffmann, and Markus Ries
Search Result 1
Cover Image

Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act by Lutz, Thomas (Author) , Lampert, Anette (Author) , Hoffmann, Georg F. (Author) , Ries, Markus (Author) ,

BioMed Central 2016

Get full text
Article (Journal) Book/Monograph Online Resource

Saved in:
Show all versions (2)

Similar Items